tradingkey.logo

Amneal Pharmaceuticals Inc

AMRX
查看详细走势图
14.520USD
-0.250-1.69%
收盘 02/06, 16:00美东报价延迟15分钟
4.56B总市值
814.81市盈率 TTM

Amneal Pharmaceuticals Inc

14.520
-0.250-1.69%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.69%

5天

+6.14%

1月

+11.78%

6月

+80.37%

今年开始到现在

+15.24%

1年

+82.18%

查看详细走势图

TradingKey Amneal Pharmaceuticals Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Amneal Pharmaceuticals Inc当前公司基本面数据相对稳定,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在药品行业排名25/159位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价14.50。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Amneal Pharmaceuticals Inc评分

相关信息

行业排名
25 / 159
全市场排名
73 / 4521
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Amneal Pharmaceuticals Inc亮点

亮点风险
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
业绩高增长
公司营业收入稳步增长,连续3年增长26.29%
估值高估
公司最新PE估值814.81,处于3年历史高位
机构加仓
最新机构持股154.72M股,环比增加0.04%
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值1.61M

分析师目标

根据 5 位分析师
买入
评级
14.500
目标均价
-1.83%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Amneal Pharmaceuticals Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Amneal Pharmaceuticals Inc简介

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
公司代码AMRX
公司Amneal Pharmaceuticals Inc
CEOPatel (Chintu)
网址https://amneal.com/
KeyAI